U.S. Opioid and Non-Opioid Pain Management Pharmaceuticals Markets

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service covers the U.S. opioid and non-opioid pain management pharmaceuticals markets and includes the long acting opioids, non-selective and selective non-steroidal anti-inflammatory drugs (NSAIDs). The research service provides a market overview, competitive structure, market forecasts and market share analysis across these two segments.

Table of Contents

U.S. Opioid and Non-Opioid Pain Management Pharmaceuticals Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Opioid and Non-Opioid Pain Management Pharmaceuticals Markets, Total U.S. Opioid and Non-Opioid Pain Management Pharmaceuticals MarketsMarket OverviewIntroductionScope and SegmentationResearch MethodologyMarket Engineering MeasurementsMarket ForecastsPatient ForecastsPricing ForecastsRevenue ForecastsCompetitive AnalysisMarket Share AnalysisProduct PipelineU.S. Opioid and Non-Opioid Pain Management Pharmaceuticals Markets, U.S. Opioid Pain Management Pharmaceuticals MarketMarket OverviewIntroductionMarket Engineering MeasurementsMarket ForecastsPatient ForecastsPricing ForecastsRevenue ForecastsCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Opioid and Non-Opioid Pain Management Pharmaceuticals Markets, U.S. Non-Opioid Pain Management Pharmaceuticals MarketMarket OverviewIntroductionMarket Engineering MeasurementsMarket ForecastsPatient ForecastsPricing ForecastsRevenue ForecastsCompetitive AnalysisCompetitive StructureMarket Share AnalysisU.S. Opioid and Non-Opioid Pain Management Pharmaceuticals Markets, Decision Support DatabasesDisease IncidenceArthritis PrevalenceDemographic IndicatorsPopulation Above 65Percent of Population Above 65Male Population Above 65Female Population Above 65Market IndicatorOTC as Percent of Total Pharma




Related Research

Release Date : 26-Sep-17

Region : North America

Release Date : 25-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.